1. Home
  2. GEF vs PRAX Comparison

GEF vs PRAX Comparison

Compare GEF & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greif Inc.

GEF

Greif Inc.

HOLD

Current Price

$65.46

Market Cap

3.7B

Sector

N/A

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$247.81

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEF
PRAX
Founded
1877
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GEF
PRAX
Price
$65.46
$247.81
Analyst Decision
Hold
Strong Buy
Analyst Count
4
13
Target Price
$69.50
$239.62
AVG Volume (30 Days)
233.9K
1.0M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
3.42%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,290,654,188.00
$7,463,000.00
Revenue This Year
$2.73
N/A
Revenue Next Year
$1.70
N/A
P/E Ratio
$3.38
N/A
Revenue Growth
N/A
364.98
52 Week Low
$48.23
$26.70
52 Week High
$70.98
$277.44

Technical Indicators

Market Signals
Indicator
GEF
PRAX
Relative Strength Index (RSI) 65.39 71.38
Support Level $65.12 $171.20
Resistance Level $66.55 $199.47
Average True Range (ATR) 1.32 17.03
MACD 0.33 1.31
Stochastic Oscillator 81.26 74.75

Price Performance

Historical Comparison
GEF
PRAX

About GEF Greif Inc.

Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: